id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2152031,92683c5b-e7cb-4e3a-9bf0-56bca99ce957,Q2,"HOOPER, LUNDY & BOOKMAN, P.C.",401020884,"BROWN RUDNICK, LLP, ON BEHALF OF PRIME THERAPEUTICS",2018,second_quarter,MMM,H.R. 1316-The Prescription Drug Price Transparency Act (MAC); H.R. 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (DIR); H.R. 1939 & S. 1044 - Ensuring Seniors Access to Local Pharmacies Act of 2017; S. 2553-Know the Lowest Price Act. CY2019 Medicare Part D Final Rule relating to direct and indirect renumeration fees; H.R.5958-The Phair Pricing Act of 2018.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2018-07-18T18:09:20.823000-04:00